New and updated guidance issued by NICE on a range of topics, including COVID-19 November 2020 NICE has issued a number of new and updated guidelines on a range of topics, including COVID-19. In its series of COVID-19 rapid guidelines, NICE […]
The Nuffield Trust publishes two neuroscience briefings November 2020 Following a review of specialised adult neuroscience services in England conducted by the NHS England Specialised Commissioning team in collaboration with other programmes such as […]
SIGN 142 on the management of osteoporosis and prevention of fragility fractures updated September 2020 The Scottish Intercollegiate Guidelines Network (SIGN) has updated SIGN 142, Management of osteoporosis and the prevention of fragility fractures. The topics covered by SIGN 142 […]
NICE issues Evidence Summary on Remsima (infliximab biosimilar) for rheumatoid arthritis August 2020 NICE has published Evidence Summary 29, Remsima (infliximab biosimilar) for subcutaneous injection for managing rheumatoid arthritis. Remsima is a biosimilar monoclonal antibody of infliximab that inhibits […]
Neurological associations of COVID-19 reported July 2020 Although primarily a respiratory disease, neurological complications of COVID-19 are increasingly being reported, according to a recent review. The complications reported in patients with COVID-19 […]
Royal Osteoporosis Society publishes guidance on care during and beyond the pandemic July 2020 The Royal Osteoporosis Society has released two new publications related to the treatment of osteoporosis during the COVID-19 pandemic: White paper: delivering core NHS and care […]
